Related references
Note: Only part of the references are listed.CXA-10, a Nitrated Fatty Acid, Is Renoprotective in Deoxycorticosterone Acetate-Salt Nephropathys
Cynthia M. Arbeeny et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
NRF2 and NF-κB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
Farzane Sivandzade et al.
REDOX BIOLOGY (2019)
Structure-Activity and Structure-Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein-Protein Interaction
Tom D. Heightman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity
Meng-Chen Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
Natalia Robledinos-Anton et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Antioxidant, Anti-inflammatory, and Neuroprotective Effects of Novel Vinyl Sulfonate Compounds as Nrf2 Activator
Ji Won Choi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study
Michael J. Palte et al.
ADVANCES IN THERAPY (2019)
Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis
Ai-Ling Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Emerging Screening Approaches in the Development of Nrf2-Keap1 Protein-Protein Interaction Inhibitors
Chung-Hang Leung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity
Kim T. Tran et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation
Meng-Chen Lu et al.
REDOX BIOLOGY (2019)
5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress
Li-Li Xu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson's Disease Therapy
Ji Won Choi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy
Zheng-Yu Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Therapeutic targeting of the NRF2 and KEAP 1 partnership in chronic diseases
Antonio Cuadrado et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia
David R. Lynch et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
The neuroprotective mechanisms and effects of sulforaphane
Eric A. Klomparens et al.
BRAIN CIRCULATION (2019)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds
Piul S. Rabbani et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Discovery of a head-to-tail cyclic peptide as the Keapl-Nrf2 protein-protein interaction inhibitor with high cell potency
Meng-Chen Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design and synthesis of new hybrids from 2-cyano-3,12-dioxooleana-9-dien-28-oic acid and O-2-(2,4-dinitrophenyl) diazeniumdiolate for intervention of drug-resistant lung cancer
Fenghua Kang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis
Ning Meng et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice
Ting-Ting Hou et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Identification of a Novel Hybridization from Isosorbide 5-Mononitrate and Bardoxolone Methyl with Dual Activities of Pulmonary Vasodilation and Vascular Remodeling Inhibition on Pulmonary Arterial Hypertension Rats
Yusheng Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases
Jakob S. Pallesen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Sulforaphane attenuates postnatal proteasome inhibition and improves spatial learning in adult mice
Aditya Sunkaria et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)
Sulforaphane Upregulates the Heat Shock Protein Co-Chaperone CHIP and Clears Amyloid-β and Tau in a Mouse Model of Alzheimer's Disease
Siyoung Lee et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Antonio Cuadrado et al.
PHARMACOLOGICAL REVIEWS (2018)
The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects
Ulrich Mrowietz et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Identification of novel Nrf2 activators from Cinnamomum chartophyllum HW Li and their potential application of preventing oxidative insults in human lung epithelial cells
Ming-Xing Zhou et al.
REDOX BIOLOGY (2018)
Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury
Li-Li Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors
Benjamin G. Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Recent progress in the development of small molecule Nrf2 modulators: a patent review (2012-2016)
Haopeng Sun et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy
Zhangjian Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
Annika S. Axelsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Discovery of benzo[g]indoles as a novel class of non-covalent Keap1-Nrf2 protein-protein interaction inhibitor
Daisuke Yasuda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
Isabel Lastres-Becker et al.
ANTIOXIDANTS & REDOX SIGNALING (2016)
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core
Li-Li Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity
Daisuke Yasuda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions
Zheng-Yu Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
Thomas G. Davies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Meng-Chen Lu et al.
MEDICINAL RESEARCH REVIEWS (2016)
A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides
Meng-Chen Lu et al.
MOLECULAR BIOSYSTEMS (2016)
The Dual Roles of NRF2 in Cancer
Silvia Menegon et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors
Meng-Chen Lu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming
Tetsuya Saito et al.
NATURE COMMUNICATIONS (2016)
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations
Luca Prosperini et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2016)
Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction
Geoff Wells
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway
B. G. Richardson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors
Chunquan Sheng et al.
CHEMICAL SOCIETY REVIEWS (2015)
Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators
Atul D. Jain et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway
Qin Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Characterization of RA839, a Noncovalent Small Molecule Binder to Keapl and Selective Activator of Nrf2 Signaling
Angelika F. Winkel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Structure-Activity and Structure-Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1-Nrf2 Protein-Protein Interaction Inhibitor
Zheng-Yu Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery and Modification of in Vivo Active Nrf2 Activators with 1,2,4-Oxadiazole Core: Hits Identification and Structure-Activity Relationship Study
Li-Li Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Prolonged and tunable residence time using reversible covalent kinase inhibitors
J. Michael Bradshaw et al.
NATURE CHEMICAL BIOLOGY (2015)
Mitigating risk in academic preclinical drug discovery
Jayme L. Dahlin et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
DIMETHYL FUMARATE ATTENUATES 6-OHDA-INDUCED NEUROTOXICITY IN SH-SY5Y CELLS AND IN ANIMAL MODEL OF PARKINSON'S DISEASE BY ENHANCING NRF2 ACTIVITY
X. Jing et al.
NEUROSCIENCE (2015)
Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents
Dhulfiqar Ali Abed et al.
ACTA PHARMACEUTICA SINICA B (2015)
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
Julia Pakpoor et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer
Akhileshwar Namani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Monitoring Keap1-Nrf2 interactions in single live cells
Liam Baird et al.
BIOTECHNOLOGY ADVANCES (2014)
Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review
Chunlin Zhuang et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis
Zheng-Yu Jiang et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2014)
Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
Zheng-Yu Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson's Disease Therapy
Seo Yeon Woo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Kinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1
Toshiaki Fukutomi et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
Anne Cleasby et al.
PLOS ONE (2014)
Crystal-contact engineering to obtain a crystal form of the Kelch domain of human Keap1 suitable for ligand-soaking experiments
Stefan Hoerer et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2013)
Nrf2 Defense Pathway: Experimental Evidence for Its Protective Role in Epilepsy
Manuela Mazzuferi et al.
ANNALS OF NEUROLOGY (2013)
Bardoxolone Brings Nrf2-Based Therapies to Light
Donna D. Zhang
ANTIOXIDANTS & REDOX SIGNALING (2013)
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism
Douglas Marcotte et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
RXRα Inhibits the NRF2-ARE Signaling Pathway through a Direct Interaction with the Neh7 Domain of NRF2
Hongyan Wang et al.
CANCER RESEARCH (2013)
Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
S. Chowdhry et al.
ONCOGENE (2013)
Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity
Rowena Hancock et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial
Zahra Bahadoran et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction
Rowena Hancock et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Synthesis, Chemical Reactivity as Michael Acceptors, and Biological Potency of Monocyclic Cyanoenones, Novel and Highly Potent Anti-inflammatory and Cytoprotective Agents
Suqing Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents
Sadagopan Magesh et al.
MEDICINAL RESEARCH REVIEWS (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
NRF2 and cancer: the good, the bad and the importance of context
Michael B. Sporn et al.
NATURE REVIEWS CANCER (2012)
Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction
Daigo Inoyama et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Small molecule modulators of antioxidant response pathway
Wooyoung Hur et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress
Michael B. Sporn et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regulation of NF-E2-Related Factor 2 Signaling for Cancer Chemoprevention: Antioxidant Coupled with Antiinflammatory
Rong Hu et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview
Ken Itoh et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Nrf2: friend or foe for chemoprevention?
Thomas W. Kensler et al.
CARCINOGENESIS (2010)
Molecular Mechanisms of Nrf2-Mediated Antioxidant Response
Wenge Li et al.
MOLECULAR CARCINOGENESIS (2009)
Physiological significance of reactive cysteine residues of keap1 in determining Nrf2 activity
Tae Yamamoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Ageing, oxidative stress and cancer: paradigms in parallax
Christopher C. Benz et al.
NATURE REVIEWS CANCER (2008)
Different electrostatic Potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response
Kit I. Tong et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Structure of the Keap1: Nrf2 interface provides mechanistic insight into Nrf2 signaling
Shih-Ching Lo et al.
EMBO JOURNAL (2006)
Keap1 recruits Neh2 through binding to ETGE and DLG motifs: Characterization of the two-site molecular recognition model
KI Tong et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
B Padmanabhan et al.
MOLECULAR CELL (2006)
Nrf2 defends the lung from oxidative stress
HY Cho et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Active defense under oxidative stress. The antioxidant responsive element
V. V. Lyakhovich et al.
BIOCHEMISTRY-MOSCOW (2006)
The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation
P Nioi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane
F Hong et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
Conserved solvent and side-chain interactions in the 1.35 Å structure of the Kelch domain of Keap1
LJ Beamer et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron
M McMahon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex
DD Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
N Wakabayashi et al.
NATURE GENETICS (2003)
Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress
DD Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants
AT Dinkova-Kostova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Naphthalene-induced respiratory tract toxicity: Metabolic mechanisms of toxicity
A Buckpitt et al.
DRUG METABOLISM REVIEWS (2002)
Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription
Y Katoh et al.
GENES TO CELLS (2001)
Oxidants, oxidative stress and the biology of ageing
T Finkel et al.
NATURE (2000)
Synthetic oleanane and ursane triterpenoids with modified rings A and C: A series of highly active inhibitors of nitric oxide production in mouse macrophages
T Honda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
